fig5
From: Peritoneal mesothelioma
![Peritoneal mesothelioma](https://image.oaes.cc/59989df9-93a6-4e5e-a8ea-c7c6e0e1b371/5200.fig.5.jpg)
Figure 5. Serum CA125, hyaluronic acid, and SMRP levels during nivolumab treatment in a recurrent mesothelioma patient.
Figure 5. Serum CA125, hyaluronic acid, and SMRP levels during nivolumab treatment in a recurrent mesothelioma patient.
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/